Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China

NCT03908307 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Edema
Retinal Vein Occlusion

Interventions

DRUG: OZURDEX

Sponsor

Allergan